Masanori Matsumoto

24PUBLICATIONS
64CO-AUTHORS
AutoimmunityHaematologyCardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 23, 2026
Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies.

|Feb 25, 2026
Impact of haemoglobin vesicles on pretransfusion testing and mitigation strategies.

Kazuto Omae, Kazuya Sakai, Hiroaki Tanaka

|Nov 13, 2025
Recurrent Thrombocytopenia During Caplacizumab Therapy in Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Kenki Saito, Kazuya Sakai, Atsushi Hamamura

|Mar 16, 2025
Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data.

Kazuya Sakai, Atsushi Hamamura, Yoshiko Yoshimura

|Aug 19, 2024
Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report.

Masahito Uchihara, Kazuya Sakai, Koki Shibata

|Feb 22, 2024
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP.

Kenki Saito, Kazuya Sakai, Masayuki Kubo

Pageof 4

Frequent Collaborators

9 joint publications

Kazuya Sakai

4 joint publications

Bernhard Lämmle

4 joint publications

Kenki Saito

2 joint publications

Erika Tarasco